Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation

被引：0

作者：

Synowiec, Agnieszka ^{[1
]}

Wcislo, Gabriel ^{[1
]}

Bodnar, Lubomir ^{[1
]}

Szczylik, Cezary ^{[1
]}

机构：

[1] Wojskowy Inst Med Warszawie, Klin Onkol, Warsaw, Poland

来源：

GINEKOLOGIA POLSKA | 2012年 / 83卷 / 01期

关键词：

BRCA1; BRCA2; ovarian cancer; prophylaxis bilateral salpingo-oophovectomy; REDUCING SALPINGO-OOPHORECTOMY; PROPHYLACTIC OOPHORECTOMY; BREAST-CANCER; HEREDITARY BREAST; FALLOPIAN-TUBE; RISK REDUCTION; BRCA1; WOMEN; SURGERY; STATEMENT;

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian cancer remains to be a real challenge in spite of considerable progress in many areas of modern medicine. The use of genetic testing for detecting mutations of the BRCA genes has been offering clinical scrutiny between mutated versions of the BRCA genes and higher risk of both breast and ovarian cancer A population survey is a method of choice to find out more efficient screening management in order to identify cancer patients who further will be treated effectively early. A review of literature on surgical PBSO (prophylactic bilateral salpingooophorectomy) in the BRCA genes mutations carriers with focus on preventive results against morbidity of ovarian cancer has been presented in the article.

引用

页码：51 / 56

页数：6

共 50 条

[41] Chemoprevention options for BRCA1 and BRCA2 mutation carriers
Eeles, RA
Powles, TJ
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 93S - 99S
[42] Clinical management of BRCA1 and BRCA2 mutation carriers
Domchek, SM
Armstrong, K
Weber, BL
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 2 - 3
[43] Adrenal tumors in BRCA1/BRCA2 mutation carriers
Barak, F
Shiri-Svredlov, R
Sade, RBB
Kruglikova, A
Friedman, E
Ben-Dor, D
Goldberg, I
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 98 (03): : 277 - 279
[44] Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers.
Moslehi, R
Modugno, F
Ness, R
Narod, S
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 274 - 274
[45] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Kornhauser, Naomi
Terry, Mary Beth
Vahdat, Linda T.
Andrulis, Irene
Buys, Saundra
Daly, Mary
John, Esther
Hopper, John L.
Cigler, Tessa
CANCER RESEARCH, 2015, 75
[46] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe
S Gershman
H T Lynch
P Ghadirian
N Tung
C Kim-Sing
O I Olopade
S Domchek
J McLennan
A Eisen
W D Foulkes
B Rosen
P Sun
S A Narod
British Journal of Cancer, 2011, 104 : 1384 - 1392
[47] Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers
Hughes, DJ
Ginolhac, SM
Coupier, I
Corbex, M
Bressac-de-Paillerets, B
Chompret, A
Bignon, YJ
Uhrhammer, N
Lasset, C
Giraud, S
Hardouin, A
Berthet, P
Peyrat, JP
Fournier, J
Nogues, C
Lidereau, R
Muller, D
Fricker, JP
Longy, M
Toulas, C
Guimbaud, R
Maugard, C
Olschwang, S
Yannoukakos, D
Durocher, F
Moisan, AM
Simard, J
Mazoyer, S
Lynch, HT
Szabo, C
Lenoir, GM
Goldgar, DE
Stoppa-Lyonnet, D
Sinilnikova, OM
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (01) : 265 - 267
[48] Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
Bernholtz, Shiri
Jakobson-Setton, Ariella
Korach, Jacob
Ben Baruch, Gilad
Laitman, Yael
Friedman, Eitan
BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 981 - 985
[49] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos
Jan Lubinski
Leonardo Salmena
Henry T Lynch
Charmaine Kim-Sing
William D Foulkes
Parviz Ghadirian
Susan L Neuhausen
Rochelle Demsky
Nadine Tung
Peter Ainsworth
Leigha Senter
Andrea Eisen
Charis Eng
Christian Singer
Ophira Ginsburg
Joanne Blum
Tomasz Huzarski
Aletta Poll
Ping Sun
Steven A Narod
Breast Cancer Research, 14
[50] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
M Ahmed
F Lalloo
A Howell
DG Evans
Breast Cancer Research, 12

← 1 2 3 4 5 →